About the Authors
- Daniela Hüser
-
Affiliation Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Andreas Gogol-Döring
-
Affiliation Institute for Computer Science, Freie Universität Berlin, Berlin, Germany
- Timo Lutter
-
Affiliation Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Stefan Weger
-
Affiliation Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Kerstin Winter
-
Affiliation Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Eva-Maria Hammer
-
Affiliation Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Toni Cathomen
-
Affiliations Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany, Department of Experimental Hematology, Hannover Medical School, Hannover, Germany
- Knut Reinert
-
Affiliation Institute for Computer Science, Freie Universität Berlin, Berlin, Germany
- Regine Heilbronn
-
* E-mail: regine.heilbronn@charite.de
Affiliation Institute of Virology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
Competing Interests
RH is an inventor of patents related to rAAV technology and owns equity in a gene therapy company that is commercializing AAV for gene therapy applications.
Author Contributions
Conceived and designed the experiments: DH RH. Performed the experiments: DH TL KW EMH. Analyzed the data: DH AGD TL SW TC KR RH. Contributed reagents/materials/analysis tools: SW. Wrote the paper: DH AGD KR RH.